Endophthalmitis Completed Phase 2 Trials for Moxifloxacin (DB00218)

Also known as: Ophthalmitis / Eye inflammation / Eye inflammation NOS

IndicationStatusPhase
DBCOND0009899 (Endophthalmitis)Completed2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02595359Intracameral Moxifloxacin for Prevention of Postcataract EndophthalmitisPrevention